Written Question·Department of Health and Social Care·UIN 107111

Blood Cancer: Immunotherapy

Tabled: 20 January 2026
Answered: 26 January 2026
Named Day

Question

Dr Caroline Johnson

ConservativeSleaford and North Hykeham

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure access to CAR-T therapy for mantle cell lymphoma patients who previously have been ineligible under the cancer drugs fund following NICE's most recent decision.

Answer

Dr Zubir Ahmed
Decisions on whether new medicines should be routinely funded by the National Health Service in England are made by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of their costs and benefits. NICE is currently r...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 107111) →